Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
476060:KOSDAQ
Onconic Therapeutics Inc
₩20,900.00
+0.72%
(+150.00) 1D
May 22, 3:30:16 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 476060...
Open
₩22,500
High
₩23,200
Low
₩20,450
Mkt. cap
949.02B
Avg. vol.
515.94K
Volume
914.89K
P/E ratio
47.00
52-wk high
₩28,900
52-wk low
₩5,000
EPS
₩445
Shares outstanding
45.41M
No. of employees
36
News stories
From sources across the web
About Onconic Therapeutics Inc
CEO-
Employees36
Founded2020
Headquarters-
SectorBiotechnology
Websiteonconic.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
9.43B
19.21B
15.58B
22.98B
Cost of goods sold
30.14M
-
420.00K
2.80M
Cost of revenue
30.14M
-
420.00K
2.80M
Research and development expenses
1.60B
-
3.63B
4.25B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.51B
10.90B
10.15B
13.94B
Operating expense
8.29B
10.90B
13.97B
18.39B
Total operating expenses
8.32B
10.90B
13.97B
18.40B
Operating income
1.11B
8.32B
1.61B
4.59B
Other non operating income
915.57K
1.09B
1.69M
3.14K
EBT including unusual items
-155.74M
9.40B
2.60B
6.44B
EBT excluding unusual items
-155.74M
9.40B
2.59B
6.44B
Income tax expense
-
-
-2.06B
16.83M
Effective tax rate
-
-
-79.24%
0.26%
Other operating expenses
45.60M
-
49.89M
65.22M
Net income
-155.74M
9.40B
4.66B
6.42B
Net profit margin
-1.65%
48.94%
29.91%
27.94%
Earnings per share
-
-
-
-
Interest and investment income
353.99M
-
376.24M
388.06M
Interest expense
-3.22M
-2.62M
-2.02M
-1.54M
Net interest expenses
350.76M
-2.62M
374.22M
386.53M
Depreciation and amortization charges
132.38M
-
137.14M
141.57M
EBITDA
1.20B
8.43B
1.74B
4.72B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer